НовостиBenzingaCanaccord Genuity Maintains Buy on Niagen Bioscience, Lowers Price Target to $9 Canaccord Genuity Maintains Buy on Niagen Bioscience, Lowers Price Target to $9 Benzinga 2026.10.31 00:43 (GMT+0) Открыть на Benzinga Другие новости